The announcement of a class action lawsuit against Applied Therapeutics, Inc. is likely to negatively impact its stock price in the short term as it raises concerns about potential financial liabilities and investor confidence. The notification of an upcoming deadline for potential recovery under federal securities laws adds urgency for affected investors.